Abnormal bone quality in cartilage oligomeric matrix protein and matrilin 3 double-deficient mice caused by increased tissue inhibitor of metalloproteinases 3 deposition and delayed aggrecan degradation.
Abstract
OBJECTIVE
Cartilage oligomeric matrix protein (COMP) and matrilin 3 are extracellular matrix proteins that are abundant in cartilage.
As adaptor molecules, both proteins bridge and stabilize macromolecular networks consisting of fibrillar collagens and proteoglycans.
Mutations in the genes coding for COMP and matrilin 3 have been linked to human chondrodysplasias, while in mice, deficiency
in COMP or matrilin 3 does not cause any pronounced skeletal abnormalities. Given the similar functions of COMP and matrilin
3 in the assembly and stabilization of the extracellular matrix, our aim was to determine whether these proteins could functionally
compensate for each other.
METHODS
To assess this putative redundancy of COMP and matrilin 3, we generated COMP/matrilin 3 double-deficient mice and performed
an in-depth analysis of their skeletal development.
RESULTS
At the newborn stage, the overall skeletal morphology of the double mutants was normal, but at 1 month of age, the long bones
were shortened and the total body length reduced. Peripheral quantitative computed tomography revealed increased metaphyseal
trabecular bone mineral density in the femora. Moreover, the degradation of aggrecan in the cartilage remnants in the metaphyseal
trabecular bone was delayed, paralleled by increased deposition of tissue inhibitor of metalloproteinases 3 (TIMP-3). The
structure and morphology of the growth plate were grossly normal, but in the center, focal closures were observed, a phenotype
very similar to that described in matrix metalloproteinase 13 (MMP-13)-deficient mice.
CONCLUSION
We propose that a lack of COMP and matrilin 3 leads to increased deposition of TIMP-3, which causes partial inactivation of
MMPs, including MMP-13, a mechanism that would explain the similarities in phenotype between COMP/matrilin 3 double-deficient
and MMP-13-deficient mice.
Links
Authors
Groma G, Xin W, Grskovic I, Niehoff A, Brachvogel B, Paulsson M, Zaucke F
Institution
University of Cologne, Cologne, Germany.
Source
Arthritis and rheumatism 64:8 2012 Aug pg 2644-54MeSH
AggrecansAging
Animals
Animals, Newborn
Bone Density
Bone and Bones
Extracellular Matrix Proteins
Glycoproteins
Mice
Mice, Inbred C57BL
Mice, Knockout
Models, Animal
Phenotype
Tissue Inhibitor of Metalloproteinase-3
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22378539
Log In

